Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy?

Ann Surg Oncol. 2022 Mar;29(3):1526-1527. doi: 10.1245/s10434-021-10830-4. Epub 2021 Oct 20.

Authors

Tahsin M Khan¹, Alexander J Rossi¹, Vera Suman², Bruce Haffty³, Jonathan M Hernandez¹, Judy C Boughey⁴

Affiliations

¹ Surgical Oncology Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
² Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
³ Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
⁴ Department of Surgery, Mayo Clinic, Rochester, MN, USA. [email protected].

PMID: 34671883
DOI: 10.1245/s10434-021-10830-4

No abstract available

Publication types

Letter

MeSH terms

Axilla / pathology
Breast Neoplasms* / drug therapy
Breast Neoplasms* / pathology
Female
Humans
Lymph Node Excision
Lymph Nodes / pathology
Neoadjuvant Therapy
Neoplasm Staging
Sentinel Lymph Node Biopsy
Sentinel Lymph Node* / pathology